Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKRO | AMGN | VRTX | BMY | GILD |
| Company | Akero Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 31.76 | 316.16 | 483.00 | 55.14 | 89.64 |
| High | 32.25 | 317.42 | 494.87 | 55.30 | 89.95 |
| Low | 31.22 | 313.02 | 474.00 | 54.72 | 89.01 |
| Last | 31.35 | 317.42 | 490.00 | 55.09 | 89.66 |
| Change | -0.70 | +0.51 | +17.20 | -0.36 | -0.18 |
| % Change | -2.18% | +0.16% | +3.64% | -0.65% | -0.20% |
| Volume | 25,119 | 160,165 | 229,137 | 747,886 | 442,411 |
| 20-Day Average Volume | 489,906 | 1,651,869 | 989,894 | 8,271,987 | 4,974,636 |
| Previous Close | 32.05 | 316.91 | 472.80 | 55.45 | 89.84 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 30.32 | 319.51 | 477.73 | 53.19 | 87.48 |
| 20-Day Raw Stochastic | 75.32% | 23.92% | 47.06% | 76.48% | 79.91% |
| 20-Day Relative Strength | 59.08% | 43.86% | 51.11% | 60.87% | 66.49% |
| Weighted Alpha | +104.57 | +14.62 | +24.27 | +15.67 | +26.03 |
| Today's Opinion | 100% Buy | 8% Buy | 56% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 8% Buy | 24% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 80% Buy | 24% Buy | 8% Sell | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.41% since 10/29/24 | -0.30% since 10/29/24 | +1.28% since 10/29/24 | +4.86% since 10/29/24 | +1.49% since 10/29/24 |
| Low | 30.13 on 10/31/24 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 52.29 on 10/30/24 | 87.48 on 10/30/24 |
| High | 32.95 on 11/01/24 | 323.40 on 10/31/24 | 486.23 on 11/05/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| 1-Month | |||||
| %Chg | +11.90% since 10/04/24 | -1.44% since 10/04/24 | +4.62% since 10/04/24 | +2.02% since 10/04/24 | +5.68% since 10/04/24 |
| Low | 26.46 on 10/07/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 51.31 on 10/15/24 | 84.17 on 10/11/24 |
| High | 32.95 on 11/01/24 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| 3-Month | |||||
| %Chg | +32.77% since 08/05/24 | -3.12% since 08/05/24 | -0.11% since 08/05/24 | +15.68% since 08/05/24 | +19.46% since 08/05/24 |
| Low | 23.42 on 08/06/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 46.22 on 08/08/24 | 72.43 on 08/12/24 |
| High | 32.95 on 11/01/24 | 339.17 on 09/23/24 | 500.25 on 08/30/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| 6-Month | |||||
| %Chg | +60.73% since 05/03/24 | +1.21% since 05/03/24 | +18.77% since 05/03/24 | +25.14% since 05/03/24 | +38.00% since 05/03/24 |
| Low | 17.86 on 06/05/24 | 295.30 on 06/13/24 | 394.03 on 05/07/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 32.95 on 11/01/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 56.20 on 10/31/24 | 90.71 on 11/04/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,225,263 | 170,284,928 | 122,030,624 | 112,462,416 | 111,850,072 |
| Shares Outstanding, K | 69,431 | 537,329 | 258,102 | 2,028,177 | 1,244,992 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -151,760,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,645,600,000 | 11,892,000,000 | 6,954,000,000 |
| Last Quarter Net Income | -55,990,000 | 2,830,000,000 | -3,593,600,000 | 1,211,000,000 | 1,614,000,000 |
| 60-Month Beta | -0.26 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.81 on 08/09/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 11/11/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.61 | 0.00 | 46.43 | 19.04 |